報價延遲最少15分鐘:2025/02/23 01:24 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.62 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.43/--
|
|
企業價值
245.82M
|
| 資產負債 |
|
每股賬面淨值
0.82
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
214.07M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/23 01:24 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt. |